Annual Drug Patent Expirations for PROTONIX+IV
Protonix Iv is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug.
The generic ingredient in PROTONIX IV is pantoprazole sodium. Two suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
